Program
Times are displayed in the event's local time (GMT +03:00)
Conference Program
12:45-12:55 Welcome by IAACI President
Alon Hershko, Hadassah Medical Center, Ein Kerem, Jerusalem
12:55-13:00 Greetings by AFI President
Jonathan Bernstein
Session 1: Food Allergy
Moderators: Ilan Dalal, Yael Levy
13:00-13:30 Urticaria: Novel Therapeutic Strategies and Treatment Modalities that are Currently in the Pipeline
Ana Gimenez Arnau, Department of Dermatology, Hospital del Mar, Institut Mar d'Investigacions Mediques, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
13:30-13:42 Oral Immunotherapy (OIT) in Walnut and Hazelnut Co-Allergic Patients: ELISA Inhibition Studies to Direct Treatment Approach
Yael Koren, Shamir Medical Center, Israel
13:43-13:55 A Clinical Pathway for the Diagnosis of Sesame Allergy in Children
Diti Machnes-Maayani, Sheba Medical Center, Israel
13:56-14:08 Food Desensitization: The Bnai Zion Medical Center Experience
Meital Almog, Bnai Zion Medical Center, Rappaport Faculty of Medicine, Technion, Israel
14:09-14:21 Oral Immunotherapy for Food Allergy in Adults
Na'ama Epstein-Rigbi, Shamir Medical Center, Israel
14:22-14:34 Food Protein-Induced Allergic Proctocolitis in Breastfed Infants is not so Benign
Shira Benor, Tel Aviv Sourasky Medical Center, Israel
14:35-14:47 Food-Allergy Provoked Atypical Hidradenitis Suppurativa
Eli Magen, Barzilai Medical Center, Ben Gurion University of the Negev, Israel
14:48-15:00 Treatment of Children with High Threshold Peanut Allergy
Soad Hajyahia, Sheba Medical Center, Israel
15:01-15:13 Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy
Liat Nachshon, Shamir Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Israel
15:13-15:45 LIVE Q&A session
Session 2: Drugs, Immunology and Covid 19
Moderators: Alon Hershko, Nancy Agmon Levin
15:45-16:15 Drug Allergy Assessments to Advance Care Quality and Patient Safety
Kimberly Blumenthal, Harvard Medical School, Boston, MA; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital; Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, USA
16:15-16:45 Precision Medicine for Common Immunologic Problems: From Allergy to COVID
Joshua D Milner, Division of Allergy, Immunology and Rheumatology, Columbia University Medical Center, New York-Presbyterian Morgan Stanley Children's Hospital, New York, USA
16:46-16:58 Potential Protective Effect of Asthma from SARS-CoV-2 Infection
Eli Magen, Barzilai Medical Center, Ben Gurion University of the Negev, Israel
16:59-17:11 Food Allergic Reactions During the COVID-19 Home-Confinement
Nadira Musallam, Bnai Zion Medical Center, Rappaport Faculty of Medicine, Technion, Israel
17:12-17:24 Racial Disparity in Covid-19 Mortality Rates - A Plausible Explanation
Yuval Tal, Hadassah, Hebrew University Medical Center, Israel
17:24-18:00 LIVE Q&A session
18:00-18:30 IAACI General Assembly
לינק לצפייה באסיפה (for Association members only)
Conference Program
Session 3: Immune Deficiency
Moderators: David Hagin, Amit Nahum
08:30-08:42 Inherited SLP76 Deficiency in Humans Causes Severe Combined Immunodeficiency, Neutrophil and Platelets Defects
Raz Somech, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel
08:43-08:55 A Novel Zeta-Associated Protein 70 Homozygous Mutation Causing Severe Combined Immunodeficiency Presenting as Neonatal Autoimmune Hemolytic Anemia
Arnon Broides, Soroka University Medical Center, Ben-Gurion University of the Negev, Israel
08:56-09:08 Hyper IgE Syndrome – Not only a STAT3 Deficiency
Idit Lachover, Meir Medical Center, Sackler School of Medicine, Tel Aviv University, Israel
09:09-09:21 Combined Immunodeficiency (CVID and CD4 lymphopenia) Withhold a High Risk of Malignancy Among Adults with Primary Immune Deficiency
Ronen Shavit, Sheba Medical Center, Israel
09:21-09:33 Chronic Demodicosis and Polyautoimmunity: Remember STAT1 Gain of Function
Oded Shamriz, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Israel
09:34-09:46 Minor clinical impact of COVID 19 pandemic on patients with primary immunodeficiency (PID) in Israel
Nufar Marcus, Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine, Tel Aviv University, Israel
09:47-10:07 Host Microbiome Interactions In Health and Disease
Eran Elinav, Department of Immunology, Weizmann Institute of Science, Israel, Division of Microbiome and Cancer, DKFZ, Heidelberg, Germany
10:08-10:35 LIVE Q&A session
Session 4: Highlights in Allergy and Immunology
Moderators: Avi Beigelman, Yuval Tal
10:35-10:47 Autoimmune Inner Ear Disease Among Patients with Selective IgA Deficiency
Eli Magen, Barzilai University Medical Center, Ben-Gurion University of the Negev, Israel
10:48-11:00 The Role of Ethnicity Among Israeli Patients with APS
Stanley Niznik, Shamir Medical Center, Israel
11:01-11:13 Allergy is Written in the Gene
Carmi Geller-Bernstein, Sheba Medical Center, Israel
11:14-11:26 Does Allergy Immunotherapy Provide Protection (Desensitization) or Cure (Tolerance)?
Menachem Rottem, Emek Medical Center, Rappaport faculty of Medicine, Technion, Israel
11:27-11:39 Iodinated Contrast Media Allergy Revisited
Alon Hershko, Hadassah Medical Center, Israel
11:40-12:15 LIVE Q&A session
Closing Remarks